TP53 and colorectal carcinoma: In this study, we aim to perform a comprehensive molecular analysis of the PI3K and TP53 signaling pathways in CRC within the Hispanic/Latino population, comparing early‐onset CRC patients with those diagnosed in Hispanic/Latino patients over the age of 50.